October 19th- Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma

October 13th- Beyond the Webinar: The 23rd International Myeloma Society Congress in Glasgow

October 19th- Teclistamab in high-risk smoldering multiple myeloma

October 12th- Beyond the Webinar: MRD in Multiple Myeloma: From Measuring Response to Guiding Treatment

October 19th- Myélome et MRD : de la prédiction à la décision!

October 12th- Actualités du Congrès IMS 2026

October 9th- Beyond Baseline Risk: Dynamic MRD-Driven Prognostication in CLL

October 5th- Rethinking Induction in Fit AML: Can Azacitidine–Venetoclax Challenge Intensive Chemotherapy?

October 5th- Prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q

September 30th- Beyond the Webinar: Unusual-Site Thrombosis in Myeloproliferative Neoplasms: When Thrombosis Comes Before the Diagnosis